A popular but high-priced pharmaceutical treatment for diabetes and conditions such as obesity, recently estimated as costing Bermudian patients $1,000 a month, is set to become “significantly” cheape...
A popular but high-priced pharmaceutical treatment for diabetes and conditions such as obesity, recently estimated as costing Bermudian patients $1,000 a month, is set to become “significantly” cheaper.
The drugs, collectively known as GLP-1s, are no... [3873 chars]